Gilad & Gilad Reseda LLC (Los Angeles), California, was relaunched Neurofencine (TM), a first of its kind clinically proven nutraceutical for resiliency of nerve functions and nerve pain-free. Neurofencine (tm) targets needs of millions of people who deal with circumstances normal nerve functions.
Reseda, CA (PRWEB) February 6, 2011.Development of Neurofencine (tm) is the result of breakthrough discoveries made and patented by the founders Gilad neuroscientist & Gilad. Their findings discovered the neuroprotective properties of natural agmatina, a metabolite of arginine amino acids and were informed by extensive scientific research around the world.
Neurofencine (tm) contains G-agmatine (TM)-Gilad's unique brand of agmatina & Gilad, as its main ingredient. G-agmatine (tm) acts as a shotgun targeting several molecular mechanisms critical to healthy nerve functions including: major neurotransmitters. potassium channels and calcium. production of nitric oxide (NO). Amine metabolism. and extracellular proteins.
G-agmatine (tm) is present in small quantities of plant foods, fish and meats. Recent clinical studies characterize its safety profile and showed that, in large quantities, G-agmatine (TM) feed is an ingredient of nutraceuticals effective functions of nerve pain-free, healthy sensory functions and muscular strength, leading to a better quality of life.
Was published the book describing these clinical trials in medicine pain (pain medicine 11: 356-368, 2010) and selected by the editors of MDLinx as one of the most-Read articles by we health professionals in the fields of Neurology and pain for the week of March 17, 2010. These findings were reported by Marco for the American Academy of Neurology meeting in Toronto in April 2010 and chosen to be presented in the highlights in the field of spine.
According to the authors, "studies show that, compared to conventional medicines, food agmatina (G-agmatine (TM)) is neuroprotective safe and effective treatment to relieve symptoms of neuropathy and improve the quality of life for people with sciatica. In addition, to promote the survival of nerve cells (i.e. neuroprotection) and appropriate axonal function (axonoprotection), G-agmatine (TM) can interact with multiple molecular targets that are committed not only as a result of nerve compression pathologies as sciatica, but also a typical consequence of injuries, metabolic diseases (e.g. diabetic neuropathy), chemotherapy-induced Neuropathies, infections (e.g. post herpatic neuralgia (tiles), HIV), fibromyalgia and other Neuropathies. And, taking into account the risks of side effects of drugs, this supplement now features an effective alternative.
Unfortunately, more than 20 million people in the United States alone handle circumstances that affect the normal functions of nerve. Neurofencine (tm) therefore has broad implications for the crowd of people around the world whose need for a dietary supplement that offer resistance of nerve functions and nerve pain-free remained unanswered until now.
Neurofencine (tm) is manufactured in the USA under the highest quality standards and regulations and is available exclusively from Gilad & Gilad. He is currently being sold directly to consumers online, practicing health professionals and selective retail stores. More information and special discounts can be found on the company website: http://www.fornervehealth.com. For wholesale offers practicing health professionals and retailers please call (toll-free): 1-888-484-4523.
About Gilad & Gilad
Gilad & Gilad LLC is a privately e.u.a in Reseda (Los Angeles), California, with the mission to provide safer and more effective products of superior quality for healthy nervous system functions and resistant to a better quality of life. Was founded in 2000 by Dr. Gad Gilad and Varda Gilad after years of scientific research and discovery-based discovery of neuroprotective properties of unique brand of G-agmatine (TM), Gilad & Gilad of agmatina. The company builds its reputation on continuous investment in solid sound scientific research and clinical studies, thus earning the confidence of the professionals and earn credibility with the public. -For more information about Gilad & Gilad, visit http://www.ForNerveHealth.com.
Contact:
Gad m. Gilad, Ph. d.
CEO, Gilad & Gilad LLC
Reseda, California.
Phone: 1-323-585-0774
Email: gmg (at) GiladandGilad (dot) com
http://www.ForNerveHealth.com
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/01/prweb5005474.htm
Source: prweb
More news in this category
沒有留言:
張貼留言